IL197362A0 - Method for reducing or alleviating inflammation in the digestive tract - Google Patents
Method for reducing or alleviating inflammation in the digestive tractInfo
- Publication number
- IL197362A0 IL197362A0 IL197362A IL19736209A IL197362A0 IL 197362 A0 IL197362 A0 IL 197362A0 IL 197362 A IL197362 A IL 197362A IL 19736209 A IL19736209 A IL 19736209A IL 197362 A0 IL197362 A0 IL 197362A0
- Authority
- IL
- Israel
- Prior art keywords
- reducing
- digestive tract
- alleviating inflammation
- subject
- alleviating
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 102000053723 Angiotensin-converting enzyme 2 Human genes 0.000 abstract 1
- 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 abstract 1
- 208000037273 Pathologic Processes Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000009054 pathological process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82507506P | 2006-09-08 | 2006-09-08 | |
| US82780706P | 2006-10-02 | 2006-10-02 | |
| PCT/US2007/077857 WO2008031014A1 (en) | 2006-09-08 | 2007-09-07 | Method for reducing or alleviating inflammation in the digestive tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL197362A0 true IL197362A0 (en) | 2009-12-24 |
Family
ID=38670723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL197362A IL197362A0 (en) | 2006-09-08 | 2009-03-03 | Method for reducing or alleviating inflammation in the digestive tract |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20080234345A1 (OSRAM) |
| EP (1) | EP2059234B1 (OSRAM) |
| JP (1) | JP2010502736A (OSRAM) |
| CN (1) | CN101568331A (OSRAM) |
| AT (1) | ATE531362T1 (OSRAM) |
| AU (1) | AU2007292247A1 (OSRAM) |
| CA (1) | CA2662535A1 (OSRAM) |
| DK (1) | DK2059234T3 (OSRAM) |
| ES (1) | ES2376493T3 (OSRAM) |
| IL (1) | IL197362A0 (OSRAM) |
| WO (1) | WO2008031014A1 (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2095819A1 (en) * | 2008-02-28 | 2009-09-02 | Maastricht University | N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors |
| US20100035848A1 (en) * | 2008-03-10 | 2010-02-11 | Stephen Richard Donahue | Therapy for disorders of the proximal digestive tract |
| WO2010093804A1 (en) * | 2009-02-12 | 2010-08-19 | Ore Pharmaceuticals, Inc. | Ace2 inhibitors for reducing gastrointestinal adverse effects of cytotoxic agents |
| WO2011108638A1 (ja) * | 2010-03-04 | 2011-09-09 | 大日本住友製薬株式会社 | 炎症性腸疾患用薬剤 |
| EP2544679B1 (en) | 2010-03-12 | 2019-05-15 | Omeros Corporation | Pde10 inhibitors and related compositions and methods |
| NZ716462A (en) | 2014-04-28 | 2017-11-24 | Omeros Corp | Optically active pde10 inhibitor |
| NZ630810A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
| MA41271A (fr) * | 2014-12-26 | 2017-10-31 | Celgene Alpine Invest Company Ii Llc | Méthodes d'utilisation d'oligonucléotides antisens ciblant smad7 |
| RU2017134509A (ru) | 2015-04-24 | 2019-04-04 | Омерос Корпорейшн | Ингибиторы pde10 и соответствующие композиции и способы |
| CA3003611C (en) | 2015-11-04 | 2022-11-01 | Omeros Corporation | Solid state forms of a pde10 inhibitor |
| GB202116266D0 (en) * | 2021-11-11 | 2021-12-29 | Bicycletx Ltd | Novel use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194556B1 (en) * | 1997-12-11 | 2001-02-27 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor |
| BR0010166A (pt) | 1999-04-30 | 2002-06-04 | Millennium Pharm Inc | Composto modulador de ace-2, composto inibidor de ace-2, métodos para o tratamento de um estado associado a ace-2 em um paciente e para inibir a hidrólise de um peptìdeo de marcação de ace-2, e, composição farmacêutica |
| US7045532B2 (en) | 1999-04-30 | 2006-05-16 | Millennium Pharmaceuticals, Inc. | ACE-2 modulating compounds and methods of use thereof |
| WO2002098448A1 (en) | 2001-06-04 | 2002-12-12 | Human Genome Sciences, Inc. | Methods and compositions for modulating ace-2 activity |
| GB0203061D0 (en) | 2002-02-08 | 2002-03-27 | Novartis Ag | Organic compounds |
| JP2006503905A (ja) * | 2002-09-24 | 2006-02-02 | コンビナトアールエックス インコーポレーティッド | 炎症性サイトカインのレベルの増大と関連する病気および障害の治療のための方法および試薬 |
| TW200509958A (en) * | 2003-02-14 | 2005-03-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| US20050203168A1 (en) * | 2004-03-11 | 2005-09-15 | The Regents Of The University Of Michigan | Angiotensin converting enzyme inhibitor use for treatment and prevention of gastrointestinal disorders |
| US7842709B2 (en) * | 2006-09-08 | 2010-11-30 | Ore Pharmaceuticals Inc. | Method for treating inflammatory diseases of the digestive tract |
-
2007
- 2007-09-07 AU AU2007292247A patent/AU2007292247A1/en not_active Abandoned
- 2007-09-07 CA CA002662535A patent/CA2662535A1/en not_active Abandoned
- 2007-09-07 ES ES07814746T patent/ES2376493T3/es active Active
- 2007-09-07 AT AT07814746T patent/ATE531362T1/de active
- 2007-09-07 CN CNA2007800394181A patent/CN101568331A/zh active Pending
- 2007-09-07 JP JP2009527579A patent/JP2010502736A/ja active Pending
- 2007-09-07 DK DK07814746.9T patent/DK2059234T3/da active
- 2007-09-07 EP EP07814746A patent/EP2059234B1/en not_active Not-in-force
- 2007-09-07 US US11/851,694 patent/US20080234345A1/en not_active Abandoned
- 2007-09-07 WO PCT/US2007/077857 patent/WO2008031014A1/en not_active Ceased
-
2009
- 2009-03-03 IL IL197362A patent/IL197362A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE531362T1 (de) | 2011-11-15 |
| DK2059234T3 (da) | 2011-11-28 |
| JP2010502736A (ja) | 2010-01-28 |
| ES2376493T3 (es) | 2012-03-14 |
| AU2007292247A1 (en) | 2008-03-13 |
| US20080234345A1 (en) | 2008-09-25 |
| EP2059234A1 (en) | 2009-05-20 |
| AU2007292247A2 (en) | 2009-03-26 |
| CN101568331A (zh) | 2009-10-28 |
| WO2008031014A1 (en) | 2008-03-13 |
| EP2059234B1 (en) | 2011-11-02 |
| CA2662535A1 (en) | 2008-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL197362A0 (en) | Method for reducing or alleviating inflammation in the digestive tract | |
| WO2009055783A3 (en) | Anti-pcsk9 and methods for treating lipid and cholesterol disorders | |
| IN2012DN02661A (OSRAM) | ||
| MX2009011749A (es) | Compuestos triciclicos como inhibidores de metaloproteinasa matricial. | |
| IL197350A0 (en) | Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof | |
| IL186749A0 (en) | Dihydrothienopyrimidines for the treatment of inflammatory diseases | |
| MX337634B (es) | Anillos intravaginales monoliticos que comprenden progesterona y metodos de manufactura y uso de los mismos. | |
| UA102097C2 (ru) | Способ лечения воспалительного заболевания с применением соединения, которое нейтрализует gm-csf, и соединения, которое нейтрализует il-17 | |
| EP2671891A3 (en) | Ang-2 inhibition to treat multiple sclerosis | |
| NZ594365A (en) | Dual targeting of miR-208a or miR-208b and miR-499 in the treatment of cardiac disorders or musculoskeletal disorders | |
| WO2008139263A3 (en) | Methods for slowing the progression of multiple sclerosis | |
| WO2010062900A3 (en) | A new family of pain producing substances and methods to produce novel analgesic drugs | |
| WO2006132959A3 (en) | Inhibition of thrombin generation | |
| HRP20190377T1 (hr) | Uporaba alfa-ketoglutarne kiseline i 5-hidroksi metilfurfurala za smanjenje oksidativnog stresa | |
| CA2837895C (en) | Methods of treating or preventing neurological diseases | |
| WO2007084651A3 (en) | Methods and kits to treat chronic inflammatory immune diseases | |
| WO2007147868A3 (en) | Prevention of muscle atrophy | |
| WO2007097980A3 (en) | Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy | |
| WO2009155070A3 (en) | Compositions and methods for treatment of inflammation and hyperkeratotic lesions | |
| MX2010002032A (es) | Uso de flibanserina para el tratamiento de sintomas vasomotores. | |
| WO2008042892A3 (en) | Fatty acid amide hydrolase inhibitors for energy metabolism disorders | |
| WO2011038924A3 (en) | Proteasome inhibitors for treating cancer | |
| MX2010013790A (es) | Composiciones y metodos para tratar inflamacion de corneas. | |
| WO2011133479A3 (en) | Combination therapy with a proteasome inhibitor and a gallium complex | |
| MX2009004296A (es) | Inhibidores de canal ih para promover insomnio. |